Latest Articles

Artificial intelligence (AI) has begun to transform the world of healthcare and researchers across the globe are now dedicated to discovering its potential. This technology has particularly struck a chord with cancer research surrounding early detection, a long-standing concern for the cancer community.

Truly understanding how our DNA influences our lives and health sometimes means moving past the DNA sequence. Epigenetics encompasses a group of heritable modifications without changes to the DNA sequence itself. Our epigenetics affects our susceptibility to a staggering number of diseases, including both cancer and obesity.

What if immunotherapy was the solution to cure Alzheimer’s disease (AD)? AD represents a major health issue as it affects an increasing number of people each year. The search for a therapy against AD is uncertain. Nevertheless, we can hope that the fast-growing advances in biotechnologies could lead to an improvement in diagnostics and a better understanding of the disease.

Single Molecule Real Time (SMRT) DNA sequencing is pretty darn popular: it featured in over 1400 publications in 2017 alone. The research to create SMRT began 20 years ago, and in this article one of the technique's creators, Jonas Korlach, explains how SMRT developed from concept to technology.

The brain has no nociceptors – the nerves that detect damage or threat of damage to our body and signal this to the spinal cord and brain. This has led to the belief that the brain feels no pain. A belief that has entered popular culture.

With the legalization of cannabis use in Canada looming, concerns are increasing over the risks associated with admitting association with the drug when crossing U.S. border.

Novel drug delivery system developed by researchers at CBIS offers a potential fix for those suffering from long-term, acute pain.

Terpenes are the relatively unresearched molecules present in cannabis products. Unlocking their potential could provide a whole new array of cannabis uses and benefits.

Ginko Bioworks and Cronos partner to facilitate the future production of lab-grown cannabis.

A new system is being introduced to allow black and gray market cannabis producers to introduce and protect their unique cannabis strains in the Canadian cannabis market.